STUDY OF LIVER ENZYME PANEL IN PATIENTS WITH METABOLIC SYNDROME

Abstract

Introduction: The term "metabolic syndrome" (MetS) refers to a group of symptoms that can include elevated blood pressure, hyperglycemia, excess body fat around the waist, and abnormal cholesterol levels. These conditions can occur in combination and increase the risk of heart disease, stroke, diabetes, insulin resistance, and nonalcoholic fatty liver disease (NAFLD). An estimated 34% of adults in the United States have MetS, according to the Third National Health and Nutrition Examination Survey. The present study is aimed to assess liver enzymes aspartate transaminase, alanine transaminase, gamma glutamyl transaminase and alkaline phosphatase in patients with metabolic syndrome and healthy controls.